ZA912467B - Inhibition of allograft and concordant xenograft rejection - Google Patents

Inhibition of allograft and concordant xenograft rejection

Info

Publication number
ZA912467B
ZA912467B ZA912467A ZA912467A ZA912467B ZA 912467 B ZA912467 B ZA 912467B ZA 912467 A ZA912467 A ZA 912467A ZA 912467 A ZA912467 A ZA 912467A ZA 912467 B ZA912467 B ZA 912467B
Authority
ZA
South Africa
Prior art keywords
allograft
inhibition
xenograft rejection
concordant xenograft
concordant
Prior art date
Application number
ZA912467A
Other languages
English (en)
Inventor
David James Graham White
James Graham White David
Johan Beyers Van Den Bogaerde
Beyers Van Den Bogaerde Johan
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of ZA912467B publication Critical patent/ZA912467B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA912467A 1990-04-09 1991-04-03 Inhibition of allograft and concordant xenograft rejection ZA912467B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ZA912467B true ZA912467B (en) 1992-12-30

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912467A ZA912467B (en) 1990-04-09 1991-04-03 Inhibition of allograft and concordant xenograft rejection

Country Status (22)

Country Link
EP (1) EP0527762B1 (enExample)
JP (1) JP3518547B2 (enExample)
CN (1) CN1040178C (enExample)
AT (1) ATE141167T1 (enExample)
AU (1) AU7555591A (enExample)
CZ (1) CZ283119B6 (enExample)
DE (1) DE69121401T2 (enExample)
DK (1) DK0527762T3 (enExample)
ES (1) ES2090325T3 (enExample)
GB (1) GB9007971D0 (enExample)
GR (1) GR3021642T3 (enExample)
HK (1) HK48597A (enExample)
IE (1) IE911153A1 (enExample)
IL (1) IL97788A (enExample)
IN (1) IN173149B (enExample)
MY (1) MY106158A (enExample)
NZ (1) NZ237739A (enExample)
PT (1) PT97277B (enExample)
SG (1) SG47465A1 (enExample)
SK (1) SK279949B6 (enExample)
WO (1) WO1991015221A1 (enExample)
ZA (1) ZA912467B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030379A2 (en) * 1999-10-27 2001-05-03 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
JP2004509171A (ja) 2000-09-29 2004-03-25 ゾーン、 ロバート ズィー. 炎症及び免疫反応の治療方法及びその組成物
NZ551308A (en) * 2004-05-14 2009-06-26 Alexion Pharma Inc Prolongation of survival of an allograft by inhibiting complement activity
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
SI3028716T1 (sl) 2006-10-10 2021-01-29 Regenesance B.V. Komplementarna inhibicija za izboljšano regeneracijo živcev
US9447176B2 (en) * 2008-11-10 2016-09-20 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
SI3011345T1 (sl) 2013-08-07 2017-12-29 Alexion Pharmaceuticals, Inc. Biomarkerski proteini za atipični hemolitični uremični sindrom (ahus)

Also Published As

Publication number Publication date
ES2090325T3 (es) 1996-10-16
SK279949B6 (sk) 1999-06-11
CZ283119B6 (cs) 1998-01-14
ATE141167T1 (de) 1996-08-15
DE69121401T2 (de) 1996-12-12
JP3518547B2 (ja) 2004-04-12
JPH05507266A (ja) 1993-10-21
DK0527762T3 (da) 1996-09-02
GR3021642T3 (en) 1997-02-28
DE69121401D1 (de) 1996-09-19
IL97788A0 (en) 1992-06-21
EP0527762A1 (en) 1993-02-24
MY106158A (en) 1995-03-31
PT97277B (pt) 1998-08-31
SG47465A1 (en) 1998-04-17
AU7555591A (en) 1991-10-30
IE911153A1 (en) 1991-10-09
CN1056240A (zh) 1991-11-20
IL97788A (en) 1998-02-08
IN173149B (enExample) 1994-02-19
NZ237739A (en) 1993-09-27
PT97277A (pt) 1992-01-31
GB9007971D0 (en) 1990-06-06
EP0527762B1 (en) 1996-08-14
HK48597A (en) 1997-04-25
CN1040178C (zh) 1998-10-14
CS9100988A2 (en) 1991-12-17
WO1991015221A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
EP0163475A3 (en) Immunoregulation
NO961345L (no) O-aryl, O-alkyl-, O-alkenyl- og O-alkynylmakrolider med immunundertrykkende aktivitet
EP0401747A3 (en) Use of rapamycin and derivatives and prodrugs thereof in the manufacture of a medicament for inhibiting transplant rejection in mammals
PL319608A1 (en) Compositions for treating irds and ards, containing at least one glucocorticosteroid in a mixture with a pulmonic surfactant
CA2179627A1 (en) Mixtures of Dideoxy-Nucleosides and Hydroxycarbamide for Inhibiting Retroviral Spread
FR2707259B1 (fr) Poche à fermeture à glissière et procédé de fabrication de celle-ci.
EP0812201A4 (en) IN VITRO AMPLIFICATION OF STEM CELLS
IN159219B (enExample)
AU2061397A (en) Immunosuppressive compounds and methods
AU1441895A (en) Mediators of chronic allograft rejection
EP0555413A4 (en) Methods and compositions for suppressing allograft rejection in mammals
AU6974294A (en) Release and mobilisation of haematopoietic cells
HU901516D0 (en) The use of s-adenosile-methionine in the treatment of pancreatitis, and in preventing the natural rejection of transplanted pancreas
IL97788A0 (en) Inhibition of allograft and concordant xenograft rejection
MY105942A (en) Cyclosporin derivatives.
AU8216691A (en) Autobiotics and their use in eliminating nonself cells in vivo
AU1123001A (en) Compositions and methods for preventing and treating transplant rejection
AU3779693A (en) Antibodies for and treatment to prevent or reduce the severity of xenograft rejection
GB2212519B (en) Vacuum evaporation and deposition
AU7781891A (en) Azeotrope-like compositions of dichloropentafluoropropane, methanol and 1,2-dichloroethylene
GB8721482D0 (en) Treating transplant rejection
GB8712479D0 (en) Treating transplant rejection
PL284247A1 (en) Method for processing full blood, blood plasma and densified blood cells
ZA929898B (en) Trestle table for camping and other activities.
GB8923712D0 (en) Compounds and methods for the amelioration of graft rejection